Detalhe da pesquisa
1.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30536609
2.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
3.
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
Breast Cancer Res Treat
; 141(1): 119-23, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23982884
4.
Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.
J Oncol Pharm Pract
; 18(2): 299-302, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22065198
5.
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Clin Breast Cancer
; 19(4): e501-e510, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31204290
6.
Paralytic ileus associated with capecitabine.
Tumori
; 94(5): 742-5, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-19112951
7.
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.
Oncotarget
; 8(34): 56921-56931, 2017 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28915642
8.
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.
J Cancer Res Clin Oncol
; 142(3): 669-78, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26531187
9.
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
Clin Breast Cancer
; 15(2): e131-7, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25454738
10.
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0136731, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26340098
11.
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0139650, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26406908